Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Clinical trial NCT06751966 · RECRUITING
Trial details
- NCT number
- NCT06751966
- Sponsor
- The First Affiliated Hospital of Nanchang University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-08-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.